These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19211378)

  • 21. Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trial.
    Feng YR; Zhu Y; Liu LY; Wang WH; Wang SL; Song YW; Wang X; Tang Y; Liu YP; Ren H; Fang H; Zhang SP; Liu XF; Yu ZH; Li YX; Jin J
    Oncotarget; 2016 May; 7(18):25576-84. PubMed ID: 27014909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
    Skelton MR; Goldberg RM; O'Neil BH
    Clin Colorectal Cancer; 2007 Jan; 6(5):386-8. PubMed ID: 17311705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Readministration of oxaliplatin using a rapid desensitization method after severe anaphylactic reaction].
    Arotçarena R; Berthélémy P; Piot M; Pariente A
    Gastroenterol Clin Biol; 2001 Feb; 25(2):206-7. PubMed ID: 11319450
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer.
    Turitto G; Panelli G; Frattolillo A; Auriemma A; de Luna FS; Cione G; De Angelis CP; Muto P; Iaffaioli RV
    Front Biosci; 2006 May; 11():1275-9. PubMed ID: 16368513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two cases of rupture of esophagogastric varices during the course of oxaliplatin-based chemotherapy for colorectal cancer].
    Shigefuku R; Takahashi H; Tsuda T; Ikeda H; Matsunaga K; Matsumoto N; Okuse C; Boku N; Itoh F; Suzuki M
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2326-36. PubMed ID: 25482909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxaliplatin-induced coronary vasospasm manifesting as Kounis syndrome: a case report.
    Chang PH; Hung MJ; Yeh KY; Yang SY; Wang CH
    J Clin Oncol; 2011 Nov; 29(31):e776-8. PubMed ID: 21969496
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
    J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer.
    Dipetrillo T; Pricolo V; Lagares-Garcia J; Vrees M; Klipfel A; Cataldo T; Sikov W; McNulty B; Shipley J; Anderson E; Khurshid H; Oconnor B; Oldenburg NB; Radie-Keane K; Husain S; Safran H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):124-9. PubMed ID: 20947267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxaliplatin-induced proximal renal tubular acidosis.
    Negro A; Grasselli C; Galli P
    Intern Emerg Med; 2010 Jun; 5(3):267-8. PubMed ID: 19937480
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extravasation of oxaliplatin into the mediastinum: a case report and review of the literature.
    Leon-Ferre RA; Abu Hejleh TB; Halfdanarson TR
    Clin Adv Hematol Oncol; 2012 Aug; 10(8):546-8. PubMed ID: 23073056
    [No Abstract]   [Full Text] [Related]  

  • 32. Oxaliplatin-induced haemolytic anaemia.
    Desrame J; Broustet H; Darodes de Tailly P; Girard D; Saissy JM
    Lancet; 1999 Oct; 354(9185):1179-80. PubMed ID: 10513718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe anaphylactic reactions to oxaliplatin.
    Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
    Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
    [No Abstract]   [Full Text] [Related]  

  • 34. [Extravasation of chemotherapeutic agents: prevention and therapy].
    Jordan K; Grothe W; Schmoll HJ
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
    Carraro S; Roca EL; Cartelli C; Rafailovici L; Castillo Odena S; Wasserman E; Gualdrini U; Huertas E; Barugel M; Ballarino G; Rodriguez MC; Masciangioli G
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):397-402. PubMed ID: 12243813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of extravasation of oxaliplatin by mimicking its biotransformation.
    Bahadori F; Demiray M
    Clin Transl Oncol; 2018 Oct; 20(10):1353-1357. PubMed ID: 29704231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results.
    Czito BG; Bendell JC; Willett CG; Morse MA; Blobe GC; Tyler DS; Thomas J; Ludwig KA; Mantyh CR; Ashton J; Yu D; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):472-8. PubMed ID: 17498568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage?
    Azaïs H; Bresson L; Bassil A; Katdare N; Merlot B; Houpeau JL; El Bedoui S; Meurant JP; Tresch E; Narducci F
    J Vasc Access; 2015; 16(1):31-7. PubMed ID: 25362986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.
    Aschele C; Cionini L; Lonardi S; Pinto C; Cordio S; Rosati G; Artale S; Tagliagambe A; Ambrosini G; Rosetti P; Bonetti A; Negru ME; Tronconi MC; Luppi G; Silvano G; Corsi DC; Bochicchio AM; Chiaulon G; Gallo M; Boni L
    J Clin Oncol; 2011 Jul; 29(20):2773-80. PubMed ID: 21606427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect.
    Hijri FZ; Arifi S; Ouattassi N; Mellas N; El Mesbahi O
    J Gastrointest Cancer; 2014 Mar; 45(1):106-8. PubMed ID: 23494572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.